SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280600-19-000044
Filing Date
2019-08-05
Accepted
2019-08-05 16:11:58
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlrn-20190630x10q.htm   iXBRL 10-Q 1304613
2 EXHIBIT 31.1 xlrn-20190630xexhibit311.htm EX-31.1 12283
3 EXHIBIT 31.2 xlrn-20190630xexhibit312.htm EX-31.2 12338
4 EXHIBIT 32.1 xlrn-20190630xexhibit321.htm EX-32.1 7816
  Complete submission text file 0001280600-19-000044.txt   5989555

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20190630.xsd EX-101.SCH 41967
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20190630_cal.xml EX-101.CAL 65726
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20190630_lab.xml EX-101.LAB 566642
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20190630_pre.xml EX-101.PRE 322871
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20190630_def.xml EX-101.DEF 201958
10 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20190630x10q_htm.xml XML 1050418
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 19998753
SIC: 2836 Biological Products, (No Diagnostic Substances)